MedTrace Logo

Speech Analysis in ALS Patients

NCT03868345 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2023-03-09

No results posted yet for this study

Summary

The purpose of this study is to find out if changes in speech can signal changes in the ability to think or remember. ALS patients with and without cognitive dysfunction will be followed for one year. Every three months, patients will undergo a series of cognitive and basic clinical outcomes tests. In addition, participants will take home a study-provided tablet on which they will complete weekly speech recording activities.

Conditions

Sponsors & Collaborators

  • Arizona State University

    collaborator OTHER

  • Barrow Neurological Institute

    lead OTHER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-18
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03868345 on ClinicalTrials.gov